Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
With a market cap of 19.81B, Moderna(MRNA) trades at $49.87. The stock has a price-to-earnings ratio of -6.13.
On 2026-06-12, Moderna(MRNA) stock traded between a low of $49.26 and a high of $51.74. Shares are currently priced at $49.87, which is +1.2% above the low and -3.6% below the high.
Moderna(MRNA) shares are trading with a volume of 5.08M, against a daily average of 5.62M.
In the last year, Moderna(MRNA) shares hit a 52-week high of $59.55 and a 52-week low of $22.28.
In the last year, Moderna(MRNA) shares hit a 52-week high of $59.55 and a 52-week low of $22.28.
MRNA News
In recent trading, shares of Moderna Inc (Symbol: MRNA) have crossed above the average analyst 12-month target price of $46.62, changing hands for $49.70/share....
Moderna (MRNA) announced an update on their ongoing clinical study. ModernaTX, Inc. (MRNA) is running a Phase 2 trial called “A Study of mRNA-1345 Vaccine Targ...
UK regulators have authorized a Phase 1/2 trial of Moderna and Oxford's mRNA-4194 preventive cancer vaccine for people with Lynch Syndrome. The first-in-human...
Analyst ratings
63%
of 27 ratingsMore MRNA News
Key Points Moderna is losing billions of dollars per year. The company has several promising new products that should be coming to the market within the next...
BofA raised the firm’s price target on Moderna (MRNA) to $34 from $32 and keeps an Underperform rating on the shares after having hosted Moderna’s CEO for a gro...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.